Drug Type CAR-NK |
Synonyms AB MK 001, AB-MK-001 |
Target- |
Mechanism Immunologic cytotoxicity, Natural killer cell replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Artiva Biotherapeutics, Inc.Startup |
Active Organization |
Inactive Organization Artiva Biotherapeutics, Inc.Startup |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Preclinical | US | Artiva Biotherapeutics, Inc.Startup | - |
Solid tumor | Preclinical | US | - |